Clinical trial
The Evaluation of the Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure in Post-Chemotherapy Cancer Patients - A Randomized Controlled Trial
NCT05091775 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Evaluation of the Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure in Post-Chemotherapy Cancer Patients - A Randomized Controlled Trial
- Lead sponsor
- Shiraz University of Medical Sciences
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 1, 2020
- Completion date
- January 10, 2021
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.